P-glycoprotein in intestines, liver, kidney and lymphocytes in horse

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 2, 2009, Pages 167-176

  Tyden E ^a   Tallkvist, J ^a   TjAlve H ^a   Larsson, P ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; GENE EXPRESSION; HORSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE CELL; KIDNEY TUBULE CELL; LIVER CELL; LYMPHOCYTE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA PRIMERS; FEMALE; HORSES; IMMUNOHISTOCHEMISTRY; INTESTINES; KIDNEY; LIVER; LYMPHOCYTES; MALE; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

EQUIDAE;

EID: 61849123016     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.01017.x     Document Type: Article

References (48)

1. Ballent, M., Lifschitz, A.C., Virlek, G., Sallovitz, J. Lanusse, C. (2007) Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition. Journal of Veterinary Pharmacology and Therapeutics, 30, 242 248.
2. Berggren, S., Gall, C., Wollnitz, N., Ekelund, M., Karlbom, U., Hoogstraate, J., Schrenk, D. Lennernäs, H. (2007) Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. Molecular Pharmacology, 4, 252 257.
3. Blokzijl, H., Vander Borght, S., Bok, L.I.H., Libbrecht, L., Geuken, M., van den Heuvel, F.A.J., Dijkstra, G., Roskams, T.A.D., Moshage, H., Jansen, P.L.M. Faber, K.N.F. (2007) Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflammatory Bowel Disease, 13, 710 720.
4. Caldwell, J.H., Caldwell, P.B., Murphy, J.W. Beachler, C.W. (1980) Intestinal secretion of digoxin in the rat. Augmentation by feeding activated charcoal. Naunyn-Schmiedeberg's Archives of Pharmacology, 312, 271 275.
5. Cascorbi, I. (2006) Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacology and Therapeutics, 112, 457 473.
6. Chaudhary, P.M., Mechetner, E.B. Roninson, I.B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 80, 2735 2739.
7. Čížková, D., Mokrý, J., Mičuda, S., Österreicher, J. Martínková, J. (2005) Expression of MRP2 and MDR1 transporters and other hepatic markers in rat and human liver and in WRL 68 cell line. Physiological Research, 54, 419 428.
8. Conrad, S., Viertelhaus, A., Orzechowski, A., Hoogstraate, J., Gjellan, K., Schrenk, D. Kauffmann, H.-M. (2001) Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. Toxicology, 156, 81 91.
9. Davis, J.L., Little, D., Blikslager, A.T. Papich, M.G. (2006) Mucosal permeability of water-soluble drugs in jejunum: a preliminary investigation. Journal of Veterinary Pharmacology and Therapeutics, 29, 379 385.
10. Drach, J., Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M. Huber, H. (1996) Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T-lymphocytes. Blood, 88, 1747 1754.
11. Eisenbraun, M.D. Miller, R.A. (1999) mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice. Journal of Immunology, 163, 2621 2627.
12. Eisenbraun, M.D., Mosley, R.L., Teitelbaum, D.H. Miller, R.A. (2000) Altered development of intestinal intraepithelial lymphocytes in P-glycoprotein-deficient mice. Developmental and Comparative Immunology, 24, 783 795.
13. Englund, G., Rorsman, F., Rönnblom, A., Karlbom, U., Lazorova, L., Gråsjö, J., Kindmark, A. Artursson, P. (2006) Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. European Journal of Pharmaceutical Sciences, 29, 269 277.
14. Ernest, S., Rajaraman, S., Megyesi, J. Bello-Reuss, E.N. (1997) Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney. Nephron, 77, 284 289.
15. Farrell, R.J., Murphy, A., Long, A., Donnelly, S., Cherikuri, A., O'Toole, D., Mahmud, N., Keeling, P.W.N., Weir, D.G. Kelleher, D. (2000) High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology, 118, 279 288.
16. Ferguson, A. (1977) Intraepithelial lymphocytes of the small intestine. Gut, 18, 921 937.
17. Georges, E., Bradley, G., Gariepy, J. Ling, V. (1990) Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 87, 152 156.
18. Ginn, P.E. (1996) Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues. Veterinary Pathology, 33, 533 541.
19. Glaeser, H., Bailey, D.G., Dresser, G.K., Gregor, J.C., Schwarz, U.I., McGrath, J.S., Jolicoeur, E., Lee, W., Leake, B.F., Tirona, R.G. Kim, R.B. (2007) Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clinical Pharmacology and Therapeutics, 81, 362 370.
20. Gramatte, T., Oertel, R., Terhaag, B. Kirch, W. (1996) Direct demonstration of small intestinal secretion and site-dependent absorption of the beta blocker talinolol in humans. Clinical Pharmacology and Therapeutics, 59, 541 549.
21. Huang, Z., Fasco, M.J. Kaminsky, L.S. (1996) Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. BioTechniques, 20, 1012 1020.
22. Idriss, H.T., Hannun, Y.A., Boulpaep, E. Basavappa, S. (2000) Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say! Journal of Physiology, 524, 629 636.
23. Jones, P. George, A. (1998) A new structural model for P-glycoprotein. Journal of Membrane Biology, 166, 133 147.
24. Keppler, D. Arias, I.M. (1997) Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane. The FASEB Journal, 11, 15 18.
25. Kyte, J. Doolittle, R.F. (1982) A simple method for displaying the hydropathic character of a protein. The Journal of Molecular Biology, 157, 105 132.
26. Laffont, C.M., Toutain, P.-L., Alvinerie, M. Bousquet-Mélou, A. (2002) Intestinal secretion is the major route for parent ivermectin elimination in the rat. Drug Metabolism and Disposition, 30, 626 630.
27. Marchetti, S., Mazzanti, R., bejnen, J.H. Schellens, J.H.M. (2007) Concise review: clinical relevance of drug-drug and herb-drug interactions mediated by the transporter ABCB1 (MDR1, P-glycoprotein). The Oncologist, 2007, 12.
28. McKie, A.T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T.J., Farzaneh, F., Hediger, A., Hentze, M.W. Simpson, R.J. (2000) A novel duodenal iron-regulated transporter, IREG, implicated in the basolateral transfer of iron to the circulation. Molecular Cell, 5, 299 309.
29. Mealey, K.L. (2004) Therapeutic implications of the MDR-1gene. Journal of Veterinary Pharmacology and Therapeutics, 27, 257 264.
30. Nakamura, T., Sakaeda, T., Ohmoto, N., Tamura, N., Aoyama, N., Shirakawa, T., Kamigaki, T., Nakamura, T., Kim, K.I., Kim, S.R., Kuroda, Y., Matsuo, M., Kasuga, M. Okumura, K. (2002) Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Drug Metabolism and Disposition, 2002, 30.
31. Olsén, L., Ingvast-Larsson, C., Bondesson, U., Broström, H., Tjälve, H. Larsson, P. (2007) Cetririzine in horses: pharmacokinetics and effect of ivermectin pretreatment. Journal of Veterinary Pharmacology and Therapeutics, 30, 194 200.
32. Park, S.W., Lomri, N.L., Simeoni, L.A., Fruehauf, J.P. Mechetner, E. (2003) Analysis of P-glycoprotein. Cytometry part A, 53A, 67 78.
33. Pavelic, Z.P., Sever, Z., Fontaine, R.N., Baker, V.V., Riesing, J., Dentón, D.M., Pavelic, L. Khalily, M. (1991) Detection of P-glycoprotein with JSB-1 antibody in B-5 fixed and paraffin-embedded lines of cells. Selective Cancer Therapeutics, 7, 49 58.
34. von Richter, O., Burk, O., Fromm, M.F., Thon, K.P., Eichelbaum, M. Kivisto, K.T. (2004) Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clinical Pharmacology and Therapeutics, 75, 172 183.
35. Schinkel, A.H. Jonker, J.W. (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Advanced Drug Delivery Reviews, 55, 3 29.
36. Taipalensuu, J., Törnblom, H., Lindberg, G., Einarsson, C., Sjöqvist, F., Melhus, H., Garberg, P., Sjöström, B., Lundgren, B. Artursson, P. (2001) Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. The Journal of Pharmacology and Experimental Therapeutics, 299, 164 170.
37. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. Willingham, M.C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences of the United States of America, 84, 7735 7738.
38. Thompson, J.D., Higgins, D.G. Gibson, T.J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acid Research, 22, 4673 4680.
39. Törneke, K., Ingvast-Larsson, C., Pettersson, K., Bergvall, K., Hdeland, M., Bondesson, U. Broström, H. (2003) Pharmacokinetics and pharamacodynamics of clemastine in healthy horses. Journal of Veterinary Pharmacology and Therapeutics, 26, 151 157.
40. Tóth, K., Vaughan, M.M., Slocum, H.K., Arredondo, M.A., Takita, H., Baker, M.A. Rustum, Y.M. (1994) New histochemical 'sandwich' staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. American Journal of Pathology, 144, 227 236.
41. Tsujimura, S., Saito, K., Nakayamada, S., Nakano, K. Tanaka, Y. (2005) Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. Arthritis & Rheumatism, 52, 1676 1683.
42. Tydén, E., Olsén, L., Tallkvist, J., Larsson, P. Tjälve, H. (2004) CYP3A in horse intestines. Toxicology and Applied Pharmacology, 201, 112 119.
43. Valverde, M.A., Díaz, M., Sepúlveda, V., Gill, D.R., Hyde, S.C. Higgins, C.F. (1992) Volume-regulated chloride channels associated with the human multidrug-resitance P-glycoprotein. Nature, 355, 830 833.
44. Wacher, V.J., Salphati, L. Benet, L.Z. (2001) Active secretion and enterocytic drug metabolism barriers to drug absorption. Advanced Drug Delivery Reviews, 46, 89 102.
45. Watkins, P.B. (1997) The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Advanced Drug Delivery Reviews, 27, 161 170.
46. Yacyshyn, B., Maksymowych, W. Bowen-Yacyshyn, B. (1999) Differences in P-glycoprotein-170 expression and activity between Crohn′s disease and ulcerative colitis. Human Immunology, 60, 677 687.
47. Zhou, S., Lim, L.Y. Chowbay, B. (2004) Herbal modulation of P-glycoprotein. Drug Metabolism Reviews, 36, 57 104.
48. Zizzadoro, C., Belloli, C., Badino, P. Ormas, P. (2002) A rapid and simple method for the separation of pure lymphocytes from horse blood. Veterinary Immunology and Immunopathology, 89, 99 104.